Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MBOT NASDAQ:NMTC NASDAQ:SNWV NASDAQ:STIM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMBOTMicrobot Medical$2.10-4.3%$2.39$1.60▼$4.67$140.70M1.061.81 million shs631,532 shsNMTCNeuroOne Medical Technologies$4.50+3.9%$4.55$3.27▼$6.96$37.89M0.643,306 shs13,445 shsSNWVSanuwave Health$15.88-0.8%$19.33$15.35▼$46.58$136.57M1.3771,468 shs22,159 shsSTIMNeuronetics$1.40-7.2%$1.49$0.80▼$4.85$97.77M1.132.15 million shs864,205 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMBOTMicrobot Medical+2.82%+4.29%-15.44%+6.83%-13.10%NMTCNeuroOne Medical Technologies-9.03%-0.46%-1.37%-9.99%+16.40%SNWVSanuwave Health+2.76%+1.72%-4.99%-37.98%-46.84%STIMNeuronetics-9.06%-25.50%+11.48%+3.08%-66.03%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMBOTMicrobot Medical$2.10-4.3%$2.39$1.60▼$4.67$140.70M1.061.81 million shs631,532 shsNMTCNeuroOne Medical Technologies$4.50+3.9%$4.55$3.27▼$6.96$37.89M0.643,306 shs13,445 shsSNWVSanuwave Health$15.88-0.8%$19.33$15.35▼$46.58$136.57M1.3771,468 shs22,159 shsSTIMNeuronetics$1.40-7.2%$1.49$0.80▼$4.85$97.77M1.132.15 million shs864,205 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMBOTMicrobot Medical+2.82%+4.29%-15.44%+6.83%-13.10%NMTCNeuroOne Medical Technologies-9.03%-0.46%-1.37%-9.99%+16.40%SNWVSanuwave Health+2.76%+1.72%-4.99%-37.98%-46.84%STIMNeuronetics-9.06%-25.50%+11.48%+3.08%-66.03%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMBOTMicrobot Medical 2.60Moderate Buy$7.50258.00% UpsideNMTCNeuroOne Medical Technologies 2.25Hold$13.50200.00% UpsideSNWVSanuwave Health 2.50Moderate Buy$51.00221.16% UpsideSTIMNeuronetics 2.00Hold$3.00114.90% UpsideCurrent Analyst Ratings BreakdownLatest NMTC, MBOT, STIM, and SNWV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2026MBOTMicrobot Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.004/10/2026MBOTMicrobot Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/30/2026SNWVSanuwave Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/30/2026SNWVSanuwave Health Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$53.00 ➝ $47.003/27/2026SNWVSanuwave Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Hold (C-)3/19/2026STIMNeuronetics Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$7.00 ➝ $3.003/13/2026NMTCNeuroOne Medical Technologies Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/2/2026NMTCNeuroOne Medical Technologies JonesTradingSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$9.00(Data available from 5/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMBOTMicrobot MedicalN/AN/AN/AN/A$1.15 per shareN/ANMTCNeuroOne Medical Technologies$12.10M3.13N/AN/A$0.85 per share5.29SNWVSanuwave Health$44.05M3.10$1.73 per share9.17$0.19 per share83.58STIMNeuronetics$149.16M0.65N/AN/A$0.38 per share3.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMBOTMicrobot Medical-$13.14M-$0.29N/AN/AN/AN/A-24.44%-23.12%5/13/2026 (Estimated)NMTCNeuroOne Medical Technologies-$3.61M-$1.02N/AN/AN/A-78.34%-119.92%-78.86%5/12/2026 (Estimated)SNWVSanuwave Health$11.81M-$0.16N/A16.72N/A26.64%-141.56%34.53%5/12/2026 (Estimated)STIMNeuronetics-$39M-$0.54N/AN/AN/A-24.48%-139.83%-27.13%N/ALatest NMTC, MBOT, STIM, and SNWV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026N/AMBOTMicrobot Medical-$0.08N/AN/AN/A$0.45 millionN/A5/12/2026Q2 2026NMTCNeuroOne Medical Technologies-$0.2267-$0.25-$0.0233-$0.25$2.58 million$2.39 million5/12/2026Q1 2026SNWVSanuwave Health-$0.14N/AN/AN/A$9.60 millionN/A5/5/2026Q1 2026STIMNeuronetics-$0.17-$0.16+$0.01-$0.16$34.17 million$34.45 million3/27/2026Q4 2025MBOTMicrobot Medical-$0.06-$0.04+$0.02-$0.04$0.11 millionN/A3/26/2026Q4 2025SNWVSanuwave Health$0.17$0.03-$0.14$0.6360$13.23 million$13.09 million3/17/2026Q4 2025STIMNeuronetics-$0.12-$0.10+$0.02-$0.10$40.84 million$41.78 million2/17/2026Q1 2026NMTCNeuroOne Medical Technologies-$0.24-$0.18+$0.06-$0.03$2.47 million$2.89 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMBOTMicrobot MedicalN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/ASTIMNeuroneticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMBOTMicrobot MedicalN/A23.3323.16NMTCNeuroOne Medical TechnologiesN/A6.415.09SNWVSanuwave Health10.081.381.05STIMNeuronetics3.591.671.50Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMBOTMicrobot Medical16.30%NMTCNeuroOne Medical Technologies16.07%SNWVSanuwave Health42.53%STIMNeuronetics53.59%Insider OwnershipCompanyInsider OwnershipMBOTMicrobot Medical4.74%NMTCNeuroOne Medical Technologies11.80%SNWVSanuwave Health14.40%STIMNeuronetics8.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMBOTMicrobot Medical2067.16 million63.98 millionOptionableNMTCNeuroOne Medical Technologies208.42 million7.43 millionOptionableSNWVSanuwave Health408.60 million7.36 millionN/ASTIMNeuronetics18069.59 million63.74 millionOptionableNMTC, MBOT, STIM, and SNWV HeadlinesRecent News About These CompaniesNeuronetics (STIM) Q1 2026 Earnings TranscriptMay 6, 2026 | finance.yahoo.comNeuronetics Q1 Earnings Call HighlightsMay 5, 2026 | marketbeat.comNeuronetics, Inc. (STIM) Q1 2026 Earnings Call TranscriptMay 5, 2026 | seekingalpha.comNeuronetics (NASDAQ:STIM) Announces Earnings Results, Beats Estimates By $0.01 EPSMay 5, 2026 | marketbeat.comNeuronetics (STIM) Reports Q1 Loss, Tops Revenue EstimatesMay 5, 2026 | zacks.comNeuronetics: Q1 Earnings SnapshotMay 5, 2026 | khou.comKNeuronetics Reports First Quarter 2026 Financial and Operating ResultsMay 5, 2026 | globenewswire.comNeuronetics (STIM) to Release Quarterly Earnings on TuesdayMay 3, 2026 | americanbankingnews.comHow The Neuronetics (STIM) Investment Story Is Evolving With A Reset Price TargetMay 2, 2026 | finance.yahoo.comShort Interest in Neuronetics, Inc. (NASDAQ:STIM) Rises By 16.4%April 30, 2026 | marketbeat.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 29, 2026 | globenewswire.comNeuronetics (STIM) Projected to Post Earnings on TuesdayApril 28, 2026 | marketbeat.comInsider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Purchases 100,000 Shares of StockApril 23, 2026 | insidertrades.comInsider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Buys 100,000 Shares of StockApril 22, 2026 | marketbeat.comNeuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference CallApril 21, 2026 | globenewswire.comNeuronetics (NASDAQ:STIM) Stock Rating Upgraded by Wall Street ZenApril 18, 2026 | marketbeat.comNeuronetics (NASDAQ:STIM) Trading Down 2.8% - Here's What HappenedApril 15, 2026 | marketbeat.comNeuronetics (STIM) Receives a Buy from Piper SandlerApril 14, 2026 | theglobeandmail.comNeuronetics Announces CFO Transition and Reaffirms 2026 OutlookApril 14, 2026 | theglobeandmail.comOptum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse PractitionersApril 13, 2026 | globenewswire.comMalvern’s Neuronetics faces sale pressure from top shareholderApril 10, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAlphabet’s Earnings Didn’t Just Beat—They Changed the StoryBy Ryan Hasson | April 30, 2026These 3 Defense Giants Beat Q1 Estimates—So Why Did Their Stocks Still Fall?By Jessica Mitacek | April 22, 2026Corning Beats Q1 Estimates but Drops 9% on Guidance MissBy Ryan Hasson | April 29, 2026Homebuilder Earnings: D.R. Horton Sticks Out as Pulte & NVR Sales TankBy Leo Miller | April 27, 2026Alcoa Rebounds as Aluminum Tightens, But a Q1 Miss Tests the RallyBy Jessica Mitacek | April 22, 2026NMTC, MBOT, STIM, and SNWV Company DescriptionsMicrobot Medical NASDAQ:MBOT$2.10 -0.10 (-4.34%) As of 11:04 AM Eastern This is a fair market value price provided by Massive. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.NeuroOne Medical Technologies NASDAQ:NMTC$4.50 +0.17 (+3.93%) As of 11:04 AM Eastern This is a fair market value price provided by Massive. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.Sanuwave Health NASDAQ:SNWV$15.88 -0.12 (-0.75%) As of 11:05 AM Eastern This is a fair market value price provided by Massive. Learn more.SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.Neuronetics NASDAQ:STIM$1.40 -0.11 (-7.24%) As of 11:05 AM Eastern This is a fair market value price provided by Massive. Learn more.Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Sony's $4 Billion Bet on Rock & Roll Royalties Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It AI Demand Fuels Strong Q1 Earnings for Constellation Energy TMC Forges a New EV Supply Chain at the Bottom of the Sea MercadoLibre Boldly Invests in Growth: Discount Deepens Manic Monday.com: The Rally Is Just the Beginning for this SaaS Leader 5 Stocks Positioned to Benefit From the AI Inference Boom Sell in May and Go Away—Starting With These 3 Stocks Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
